Nancy M. Holekamp, MD is a Professor of Clinical Ophthalmology at the Washington University School of Medicine in St. Louis, Missouri. She is also Director of Retina Services at the Pepose Vision Institute in St. Louis. She has been actively involved in more than 30 national clinical trials dealing with age-related macular degeneration, retinal vascular occlusion, and diabetic retinopathy. Her efforts in research have resulted in 74 peer-reviewed publications, 21 book chapters, and more than 100 speaking invitations. She served on the AAO Ethics Committee for 6 years.

Financial disclosure: Dr. Holekamp has/had an affiliation (financial or otherwise) with a commercial organization:

1. Acucela
2. Allergan
3. Clearside
4. Gemini
5. Genentech
6. Graubug
7. Gyroscope
8. Katalyst
9. Kodiak Sciences
10. Lineage Cell Therapeutics
11. Notal Vision
12. Novartis
13. Regeneron
14. Spark Viewpoint Therapeutics